Smart choice clinical trial
WebHahn, Joo Yong ; Song, Young Bin ; Oh, Ju Hyeon et al. / Effect of P2Y12 Inhibitor Monotherapy vs Dual Antiplatelet Therapy on Cardiovascular Events in Patients … WebDec 5, 2024 · The SMART trial was a non-blinded, cluster-randomized, multiple-crossover trial among critically ill adults admitted to 5 ICUs at Vanderbilt University; Patients enrolled received either the clinician’s choice of lactated Ringer’s solution or Plasma-Lyte A vs saline (0.9% sodium chloride) for intravenous fluid; Outcomes:
Smart choice clinical trial
Did you know?
WebControversy remains regarding the optimal antiplatelet regimen in patients with acute coronary syndrome (ACS). This study sought to investigate the efficacy and safety of P2Y12 inhibitor monotherapy compared with conventional dual antiplatelet therapy (DAPT) and aspirin monotherapy in patients with ACS undergoing percutaneous coronary intervention. … WebDec 21, 2024 · Methods and Results. The SMART‐CHOICE (Smart Angioplasty Research Team: Comparison Between P2Y12 Antagonist Monotherapy vs Dual Anti‐ platelet …
WebMay 1, 2024 · The Japanese version of the HBR (J-HBR) criteria have been of the SMART-DATE (Safety of 6-month Duration of Dual Antiplatelet Therapy after Acute Coronary Syndromes) and SMART-CHOICE trials showed ... WebSep 7, 2024 · However, REDUCE and SMART-CHOICE trials only reported the data of BARC 2, 3, or 5 in patients with ACS. Fifth, a result of this is a study-level meta-analysis. There is no …
WebTel: (718) 414-2596 1250 Hylan Blvd, Suite 9B. Fax: (929) 274-7419 Staten Island, NY 10305 WebYour In-Home Care Solution Company. Our team of after-surgery care experts know the right questions to ask your discharge planner, nurse, or surgical coordinator, so we can create a …
WebJul 9, 2024 · Treatment. Official Title: Pilot Test of Contingency Management and Brief Motivational Interviewing + Substance Free Activity Session Interventions + Mindfulness-Based Adherence Promotion. Actual Study Start Date : August 17, 2024. Actual Primary Completion Date : July 31, 2024. Actual Study Completion Date :
WebJun 25, 2024 · Therefore, the Smart Angioplasty Research Team: Comparison Between P2Y12 Antagonist Monotherapy vs Dual Antiplatelet Therapy in Patients Undergoing … cynthia rowley blouses and topsWebStudy design: The SMART-CHOICE trial is a prospective, open-label, multi-center, and randomized study designed to test the non-inferiority of P2Y12 inhibitor monotherapy compared with aspirin plus a P2Y12 inhibitor after mandatory 3-month DAPT in patients undergoing PCI with current-generation DES. A total of 3000 patients will be randomized … cynthia rowley clothing blousesWebNov 1, 2024 · A recent randomized clinical trial comparing aspirin and clopidogrel as chronic maintenance therapy after PCI demonstrated that clopidogrel monotherapy was superior … cynthia rothrock upcoming moviesWebJul 9, 2024 · The SMART-CHOICE trial sought to explore 12-month clinical outcomes after second-generation DES implantation by comparing patients randomized to 3 months of … cynthia shopoffWebP2Y12 Inhibitor Monotherapy Versus Conventional Dual Antiplatelet Therapy or Aspirin Monotherapy in Acute Coronary Syndrome: A Pooled Analysis of the SMART-DATE and SMART-CHOICE Trials for the SMART-DATE and the SMART-CHOICE investigators cynthia schloss you tubeWebJul 1, 2024 · Acknowledgment: This study was supported by unrestricted grants from the Korean Society of Interventional Cardiology (grant number 2013-3), Abbott Vascular, Biotronik, and Boston Scientific.. Clinical Trial Registration: ClinicalTrials.gov Identifier - NCT01701453 and NCT02079194 cynthia teter hutchinson ksWebHowever, HPR was significantly associated with an increased risk of MACCE in clopidogrel-treated patients regardless of maintenance of aspirin. Clinical Trial Registration: Comparison Between P2Y 12 Antagonist Monotherapy and Dual Antiplatelet Therapy After DES (SMART-CHOICE) (ClinicalTrials.gov: NCT02079194). cynthia simmons psu